Acquired and Congenital Thrombo-Hemorrhagic Disorders: The Clinical Plot Has Thickened

Hemorrhagic and Thrombotic disorders, either congenital or acquired, constitute an important aspect of

[1]  S. Nair,et al.  Molecular defect of 'Prothrombin Amrita': substitution of arginine by glutamine (Arg553 to Gln) near the Na(+) binding loop of prothrombin. , 2013, Blood cells, molecules & diseases.

[2]  J. Brandt,et al.  Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. , 1985, Blood.

[3]  J. Griffin,et al.  Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency. , 1987, Archives of dermatology.

[4]  B. Colvin,et al.  Thrombogenic potential of factor XI concentrate , 1994, The Lancet.

[5]  R. Cervera,et al.  Diagnosis and classification of the antiphospholipid syndrome. , 2014, Journal of autoimmunity.

[6]  O. Rawley,et al.  Elevated factor VIII levels and risk of venous thrombosis , 2012, British journal of haematology.

[7]  A. Girolami,et al.  Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  A. Schmaier.  Alzheimer disease is in part a thrombohemorrhagic disorder , 2016, Journal of thrombosis and haemostasis : JTH.

[9]  A. Bertomoro,et al.  Congenital deficiencies and abnormalities of prothrombin. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  W. Friedenberg,et al.  Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders , 1992, American journal of hematology.

[11]  T. Warkentin,et al.  Heparin‐induced thrombocytopenia: pathogenesis and management , 2003, British journal of haematology.

[12]  R. Pesavento,et al.  Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature. , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  D. Radojkovic,et al.  A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population , 2013, Journal of thrombosis and haemostasis : JTH.

[14]  S. Ferrari,et al.  Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients. , 2013, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[15]  M. Braun,et al.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. , 2006, JAMA.

[16]  A. Lombardi,et al.  Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden , 2017, Annals of Hematology.

[17]  R. Bick.  Vascular thrombohemorrhagic disorders: hereditary and acquired. , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[18]  G. Ingram,et al.  Fatal pulmonary embolus in congenital fibrinopenia. Report of two cases. , 1966, Acta haematologica.

[19]  A. Greinacher.  CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. , 2015, The New England journal of medicine.

[20]  C. Samama.  Prothrombin complex concentrates: a brief review , 2008, European journal of anaesthesiology.

[21]  C. Kessler,et al.  Skin necrosis following prolonged administration of coumarin in a patient with inherited protein S deficiency , 1991, American journal of hematology.

[22]  F. Lo Coco,et al.  Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. , 2014, Thrombosis research.

[23]  A. Tripodi,et al.  Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[24]  M. Samama,et al.  Familial Dysfibrinogenemia and Thrombophilia , 1995, Thrombosis and Haemostasis.

[25]  M. Mosesson,et al.  Dysfibrinogenemia and Thrombosis , 1999, Seminars in thrombosis and hemostasis.

[26]  J. Lusher,et al.  Thrombogenicity associated with factor IX complex concentrates. , 1991, Seminars in hematology.

[27]  J. Kruh,et al.  Antiphospholipid antibody syndrome , 2012, Current opinion in ophthalmology.

[28]  H. Wada,et al.  Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines , 2014, Journal of Intensive Care.

[29]  C. Knupp,et al.  Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia. , 1998, Blood.

[30]  F. Blais,et al.  Coumarin-induced skin necrosis , 1991, The Journal of the American Osteopathic Association.

[31]  P. Knöbl.  Inherited and Acquired Thrombotic Thrombocytopenic Purpura (TTP) in Adults , 2014, Seminars in Thrombosis & Hemostasis.

[32]  T. Barbui,et al.  Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): First report from the Italian Registry , 1993 .

[33]  A. Girolami,et al.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature , 2009, Journal of Thrombosis and Thrombolysis.

[34]  Wenman Wu,et al.  Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation , 2016, Thrombosis and Haemostasis.

[35]  A. Lombardi,et al.  The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency , 2010, Journal of Thrombosis and Thrombolysis.

[36]  Takashi Ito,et al.  PAMPs and DAMPs as triggers for DIC , 2014, Journal of Intensive Care.

[37]  G. Federspil,et al.  Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature. , 2005, European journal of endocrinology.

[38]  A. Veyradier,et al.  Thrombotic thrombocytopenic purpura: from diagnosis to therapy , 2015, Current opinion in critical care.

[39]  M. Margaglione,et al.  Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[40]  J. Amiral,et al.  Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia , 1992, Thrombosis and Haemostasis.

[41]  X. Zheng.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. , 2015, Annual review of medicine.

[42]  R. Hoffman,et al.  Thrombohemorrhagic complications of myeloproliferative disorders. , 2010, Blood reviews.

[43]  M. Levi,et al.  DIC: which laboratory tests are most useful. , 2011, Blood reviews.

[44]  Yulia Einav,et al.  Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. , 2014, Autoimmunity reviews.

[45]  U. Seligsohn,et al.  Thromboembolic events in patients with severe inherited fibrinogen deficiency , 2016, Journal of Thrombosis and Thrombolysis.

[46]  T. Rosenberg,et al.  Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. , 1961, The American journal of medicine.

[47]  S. Ferrari,et al.  Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[48]  A. Lombardi,et al.  Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[49]  Philip Smith,et al.  Bilateral adrenal hemorrhage: The unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia* , 2011, Critical care medicine.

[50]  F. Rodeghiero,et al.  Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo‐ and afibrinogenemia , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[51]  A. Pizon,et al.  Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages , 2015 .

[52]  F. Rodríguez-Erdmann.  Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). , 1965, The New England journal of medicine.

[53]  M. Verstraete,et al.  EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS. , 1965, The American journal of medicine.

[54]  R. De Cristofaro,et al.  Congenital Prothrombin Deficiency: An Update , 2013, Seminars in Thrombosis & Hemostasis.

[55]  F. Fabris,et al.  Heparin-induced thrombocytopenia. , 2000, Haematologica.

[56]  V. Arruda,et al.  X-linked thrombophilia with a mutant factor IX (factor IX Padua). , 2009, The New England journal of medicine.

[57]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[58]  Y. Miyawaki.  Thrombosis from a prothrombin mutation conveying antithrombin resistance , 2013 .

[59]  A. Girolami,et al.  Heparin-induced thrombocytopenia: a review. , 2006, Seminars in thrombosis and hemostasis.

[60]  P. Simioni,et al.  New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[61]  T. Barbui,et al.  A new procoagulant in acute leukemia. , 1988, Blood.

[62]  T. McCaffrey,et al.  Asymptomatic factor VII deficiency: gene analysis and structure–function relationships , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.